News

Cosmos Pharma NV makes takeover offer for Cassiopea S.p.A

Read time: 1 mins

Published:4th Oct 2021

Today, Cosmo Pharmaceuticals N.V. launches a public exchange offer under Swiss takeover rules to fully acquire and delist Cassiopea S.p.A. The exchange ratio follows current market prices.

Type: industry

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Related news and insights

Industry news

Antibe Therapeutics has receiver appointed.

Antibe Therapeutics Inc. announced that the Company’s request for an extension of its previously announced stay of proceedings under the Companies’ Creditors Arrangement Act (the “CCAA”) was heard before the Ontario Superior Court of Justice (Commercial List) (the “Court”) on April 18, 2024 and the decision was reserved

1 mins

Industry news

TreeFrog Therapeutics licenses C-Stem technology to Vertex Pharma

Vertex Pharmaceuticals Incorporated and TreeFrog Therapeutics announced that Vertex has obtained an exclusive license to TreeFrog's proprietary cell manufacturing technology, C-Stem, to optimize production of Vertex's cell therapies for type 1 diabetes (T1D)

1 min

Industry news

Bruker to acquire assets of Nanostring

Bruker will pay about $392.6 million in cash to acquire most of the assets of Nanostring, a provider of research tools for spatial biology and gene expression according to Nanostring

1 min

See all news